We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · January 14, 2019

High Prevalence of Neutralizing Antibodies After Long-Term Botulinum Neurotoxin Therapy

Neurology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Neurology
High Prevalence of Neutralizing Antibodies After Long-Term Botulinum Neurotoxin Therapy
Neurology 2019 Jan 01;92(1)e48-e54, P Albrecht, A Jansen, JI Lee, M Moll, M Ringelstein, D Rosenthal, H Bigalke, O Aktas, HP Hartung, H Hefter

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading